The QMAX circumvents the major sources of complications associated with current glaucoma treatment surgeries by facilitating the drainage of aqueous fluid into a naturally fluid-filled space around the optic nerve.

  • No dangerous, unsightly, and costly bleb formation
  • Potential for unmatched, sustained long-term eye pressure control
  • Possible treatment for high and normal-tension glaucoma
  • No toxic anti-fibrotic agent required

The QFLOW is a Minimally Invasive Glaucoma Surgery “MIGS” device that leverages and improves on existing devices. The QFLOW was developed with input from leading glaucoma surgeons around the world to create the ideal bleb-forming glaucoma device.

  • Minimally invasive implantation
  • Reduced risk of endothelial damage
  • Patented adjustability for patient-specific outcomes
  • Optimized outflow configuration for more sustained IOP control

Route to Market